NCT06654440View on ClinicalTrials.gov

A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

October 31, 2026

Conditions

Advanced Gynecological Malignancy

Interventions

DRUG

SHR-A2102 for injection

SHR-A2102 for injection

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Shanghai Hengrui Pharmaceutical Co., Ltd.

INDUSTRY